The Systemic Immune Inflammatory Response Index Can Predict the Clinical Prognosis of Patients with Initially Diagnosed Coronary Artery Disease
Authors:
Open Access
- 1 November 2023
- journal article
- research article
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 16, 5069-5082
Abstract
Background: Recently, the systemic immune inflammatory response index (SIIRI), a novel and expanded inflammatory response marker, has been an independent predictor of lesion severity in patients with acute coronary syndrome (ACS). However, its predictive role in patients with initially diagnosed coronary artery disease (CAD) remains to be explored. Patients and Methods: We evaluated 959 patients with CAD undergoing an initial coronary intervention. Each patient had laboratory measurements, including blood cell counts, taken after admission and before interventional treatment. The primary endpoint was major cardiovascular events (MACEs), defined as cardiovascular death, nonfatal myocardial infarction(MI), and nonfatal stroke. The secondary endpoints included MACEs and readmission for congestive heart failure(HF). Results: During a mean follow-up period of 33.3± 9.9 months, 229 (23.9%) MACEs were recorded. ROC curve analysis displayed that the best cut-off value of SIIRI for predicting MACEs was 247.17*1018/L2. Kaplan-Meier survival curve analysis showed that the survival rate of the low SIIRI group was higher than that of the high SIIRI group (P< 0.001). Compared with the low SIIRI group, the high SIIRI group had a significantly higher risk of MACEs (187 cases (39.53%) vs.42 patients (8.64%), P< 0.001). Univariate and multivariate Cox regression analyses displayed that high SIIRI levels were independently associated with the occurrence of MACEs in patients with initially diagnosed CAD undergoing percutaneous coronary intervention (PCI) (adjusted hazard ratio [HR]: 3.808, 95% confidence interval [CI%]: 2.643– 5.486, P< 0.001). Adding SIIRI to conventional risk factor models improved the predictive value of MACEs. Conclusion: Elevated SIIRI is associated with adverse cardiovascular prognosis in patients with initially diagnosed CAD. SIIRI can be a simple and practical index to identify high-risk patients with CAD after PCI.Keywords
This publication has 62 references indexed in Scilit:
- Systemic Immune-Inflammation Index Predicts Prognosis of Patients after Curative Resection for Hepatocellular CarcinomaClinical Cancer Research, 2014
- Leukocyte Behavior in Atherosclerosis, Myocardial Infarction, and Heart FailureScience, 2013
- Neutrophil/lymphocyte ratio is related to the severity of coronary artery disease and clinical outcome in patients undergoing angiographyAtherosclerosis, 2012
- Monocyte and Macrophage Dynamics During AtherogenesisArteriosclerosis, Thrombosis, and Vascular Biology, 2011
- Mechanisms of platelet activation: Need for new strategies to protect against platelet-mediated atherothrombosisThrombosis and Haemostasis, 2009
- Predictive value of elevated neutrophil–lymphocyte ratio on cardiac mortality in patients with stable coronary artery diseaseClinica Chimica Acta, 2008
- Cancer-related inflammationNature, 2008
- Platelet Activation and AtherothrombosisNew England Journal of Medicine, 2007
- Platelets as Immune CellsCirculation Research, 2007
- Inflammation and metabolic disordersNature, 2006